Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|October 4, 2012
Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agentsSantosh Kumar, Avinash Tiwari, S N Suryawanshi, et al.
Acta Tropica|June 30, 2015
Leptin augments protective immune responses in murine macrophages and enhances potential of miltefosine against experimental visceral leishmaniasisRahul Shivahare, Wahid Ali, Preeti Vishwakarma, et al.
Journal of Leukocyte Biology|August 30, 2023
Dengue virus infection in mice induces bone marrow myeloid cell differentiation and generates Ly6Glow immature neutrophils with modulated functionsShweta Duggal, Surender Rawat, Gazala Siddqui, et al.
Microbes and Infection|June 7, 2021
Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivoNaveen Yadav, Preeti Vishwakarma, Ritika Khatri, et al.
Vaccine|October 26, 2019
Reciprocal changes in CD11c+CD11b+ and CD11c+CD8α+ dendritic cell subsets determine protective or permissive immune response in murine experimental VLPawan Kumar Yadav, Pragya Chandrakar, Pankaj Sharma, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Synthesis and biological evaluation of indolyl glyoxylamides as a new class of antileishmanial agentsShikha S Chauhan, Leena Gupta, Monika Mittal, et al.
Human Vaccines & Immunotherapeutics|January 30, 2026
Pentameric M2e influenza vaccine candidate generates strong immunity with limited survival benefitVarun Kumar, Preeti Vishwakarma, Sneha Raj, et al.
Plos One|April 16, 2014
Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasisRahul Shivahare, Preeti Vishwakarma, Naveen Parmar, et al.
The Journal of Antimicrobial Chemotherapy|November 13, 2014
Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasisSuman Gupta, Vanessa Yardley, Preeti Vishwakarma, et al.
Medical Microbiology and Immunology|December 30, 2022
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivityRitika Khatri, Gazala Siddqui, Srikanth Sadhu, et al.
Pageof 4